Supply Top Quality 99% Anti-Ulcer CAS 90098-04-7 Rebamipide

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: 90098-04-7
• Application: Stomach Ulcer and Gastritis Treatment
• Used: Anti-Ulcer
• Product Name: Rebamipide
• Other Name: Rebamipide Powder
• CAS No.: 90098-04-7
• Type: Pharmaceutical Intermediate
• Transport Package: Bag; Drum
• Specification: 1kg; 25kg
• Trademark: SHUNYI
• Origin: China
• Production Capacity: 2000kg/Month

Product Description

Supply Top Quality 99% Anti-Ulcer CAS 90098-04-7 Rebamipide
 

Product Name: Rebamipide
CAS:90098-04-7
MF:C19H15ClN2O4
MW:370.79
EINECS:1308068-626-2
MDL No.:MFCD00866895
Melting point:288-290°C dec.
Boiling point:695.0±55.0 °C(Predicted)
Density 1.394±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,Room Temperature
solubility DMSO: >5mg/mL
pka3.38±0.10(Predicted)
form powder
color white


COA
 

Item	Specification	Results
Character	White crystalline powder	Complies
	Soluble in N, N-dimethylformamide, slightly soluble in methanol, insoluble in water.	Complies
Identification	Positive reaction	Positive reaction
	The absorbance ratio at 328nm and 230nm should be 0.14-0.17	Complies
	The infrared absorption spectrum of this product should be consistent with the reference spectrum (spectral set 1067)	Complies
Chloride	NMT 0.028%	Complies
Related substance	NMT 0.5%	0.16
Acetone	NMT 0.5%	0.003
Methanol	NMT 0.3%	0.007
Ethanol	NMT 0.5%	Not detected
Loss on drying	NMT 2.0%	1.28
Residue on ignition	NMT 0.1%	0.06
Heavy metals	NMT 10ppm	Complies
Assay (on drying basis)	NLT 99%	99.89%
Conclusion	Qualified

Studies have shown that rebamipide can fight the damaging effects of NSAIDs on the GIT mucosa, and more recently, the small intestine. It has also been studied for the treatment of Behçet's disease. It was shown to successfully treat pouchitis in a single-N study after first-line therapies for the condition were unsuccessful. Some studies have shown effectiveness in presbyacusis (age-related hearing loss).; It has also been shown to alleviate signs and symptoms of dry eyes in a randomised controlled trial although this is not yet widely available clinically.